[Use of Celestene by ionization in the treatment of rheumatic diseases].
The authors report a series of 154 cases reports of 89 female and 65 men who were treated by dielectrolysis using a corticosteroid, bethamethasone phosphate (Celestene injectable). The ionization technique is recalled as: nature of the current, generator, electrodes, methods, as well as the protocol. Patients suffered mostly from rheumatologic diseases in particular scapulohumeral periarthritis, arthrosis, epicondylitis and abarticular syndromes, often long-standing and resistant to current therapeutics. This serie also comprises 15 Dupuytren's contractures and La Peyronie's diseases. The very favorable results state as good and very good in 82%. The authors emphasize the excellent tolerance of this therapeutic method which allows a profitable utilization of corticotherapy without any risk.
D001623:Betamethasone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D004387:Dupuytren Contracture / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007478:Iontophoresis; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy; D010411:Penile Induration / Q000188:drug therapy*; D010489:Periarthritis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*
D001623:Betamethasone
L'utilisation du célestène en ionisation dans le traitement des affections rhumatologiques.